1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ALLAKOS INC
Allakos Inc XNAS: ALLK

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Allakos Inc is on 07 Aug 2025 for the purpose of Allakos Inc Second Quarter Earnings Results for 2025 See details


Insider Trading disclosures for Allakos Inc

The latest disclosure was made by H. Baird Radford in Allakos Inc where a trade of 194,144 Stock Option (right to buy) done was reported to US exchanges on May 15, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
H. Baird Radford Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 15 May 2025 194,144 0 - - Stock Option (right to buy)
H. Baird Radford Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 15 May 2025 27,600 0 - - Stock Option (right to buy)
H. Baird Radford Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 15 May 2025 163,426 0 (0%) 0% - Common Stock
Robert E. Andreatta Director Sale or transfer of securities back to the company at price $ 0.00 per share. 15 May 2025 99,590 0 - - Stock Option (right to buy)
Robert E. Andreatta Director Sale or transfer of securities back to the company at price $ 0.00 per share. 15 May 2025 7,700 0 - - Stock Option (right to buy)
Robert E. Andreatta Director Sale or transfer of securities back to the company at price $ 0.00 per share. 15 May 2025 37,600 0 - - Stock Option (right to buy)
Robert E. Andreatta Director Sale or transfer of securities back to the company at price $ 0.00 per share. 15 May 2025 7,700 0 - - Stock Option (right to buy)
Robert E. Andreatta Director Sale or transfer of securities back to the company at price $ 0.00 per share. 15 May 2025 16,000 0 - - Stock Option (right to buy)
Robert E. Andreatta Director Sale or transfer of securities back to the company at price $ 0.00 per share. 15 May 2025 41,000 0 - - Stock Option (right to buy)
Robert E. Andreatta Director Sale or transfer of securities back to the company at price $ 0.00 per share. 15 May 2025 86,762 0 - - Stock Option (right to buy)
Steven P. James Director Sale or transfer of securities back to the company at price $ 0.00 per share. 15 May 2025 16,000 0 - - Stock Option (right to buy)
Steven P. James Director Sale or transfer of securities back to the company at price $ 0.00 per share. 15 May 2025 55,380 0 - - Stock Option (right to buy)
Steven P. James Director Sale or transfer of securities back to the company at price $ 0.00 per share. 15 May 2025 18,800 0 - - Stock Option (right to buy)
Steven P. James Director Sale or transfer of securities back to the company at price $ 0.00 per share. 15 May 2025 7,700 0 - - Stock Option (right to buy)
Steven P. James Director Sale or transfer of securities back to the company at price $ 0.00 per share. 15 May 2025 7,700 0 - - Stock Option (right to buy)
Steven P. James Director Sale or transfer of securities back to the company at price $ 0.00 per share. 15 May 2025 99,590 0 - - Stock Option (right to buy)
Steven P. James Director Sale or transfer of securities back to the company at price $ 0.00 per share. 15 May 2025 86,762 0 - - Stock Option (right to buy)
Steven P. James Director Sale or transfer of securities back to the company at price $ 0.00 per share. 15 May 2025 41,000 0 - - Stock Option (right to buy)
Robert Alexander Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 15 May 2025 462,325 0 - - Stock Option (right to buy)
Robert Alexander Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 15 May 2025 738,104 0 (0%) 1% - Common Stock
Robert Alexander Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 15 May 2025 320,300 0 (0%) 0% - Common Stock
Robert Alexander Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 15 May 2025 912,500 0 - - Stock Option (right to buy)
Robert Alexander Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 15 May 2025 290,022 0 - - Stock Option (right to buy)
Robert Alexander Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 15 May 2025 306,960 0 - - Stock Option (right to buy)
Robert Alexander Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 15 May 2025 250,000 0 - - Stock Option (right to buy)
Robert Alexander Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 15 May 2025 2,000,000 0 - - Stock Option (right to buy)
Dolca Thomas Director Sale or transfer of securities back to the company at price $ 0.00 per share. 15 May 2025 41,000 0 - - Stock Option (right to buy)
Dolca Thomas Director Sale or transfer of securities back to the company at price $ 0.00 per share. 15 May 2025 154,786 0 - - Stock Option (right to buy)
Amy L. Ladd Director Sale or transfer of securities back to the company at price $ 0.00 per share. 15 May 2025 41,000 0 - - Stock Option (right to buy)
Amy L. Ladd Director Sale or transfer of securities back to the company at price $ 0.00 per share. 15 May 2025 233,177 0 - - Stock Option (right to buy)
Amy L. Ladd Director Sale or transfer of securities back to the company at price $ 0.00 per share. 15 May 2025 86,762 0 - - Stock Option (right to buy)
Neil Graham Director Sale or transfer of securities back to the company at price $ 0.00 per share. 15 May 2025 41,000 0 - - Stock Option (right to buy)
Neil Graham Director Sale or transfer of securities back to the company at price $ 0.00 per share. 15 May 2025 154,786 0 - - Stock Option (right to buy)
Robert Alexander Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.26 per share. 06 Mar 2025 31,370 738,104 (1%) 0% 0.3 8,156 Common Stock
H. Baird Radford Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.26 per share. 05 Mar 2025 14,161 163,426 (0%) 0% 0.3 3,682 Common Stock
Adam Tomasi President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.26 per share. 05 Mar 2025 20,017 512,630 (1%) 0% 0.3 5,204 Common Stock
H. Baird Radford Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.10 per share. 06 Dec 2024 13,138 177,587 (0%) 0% 1.1 14,452 Common Stock
Adam Tomasi President Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.10 per share. 06 Dec 2024 21,116 532,647 (1%) 0% 1.1 23,228 Common Stock
Robert Alexander Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.10 per share. 05 Dec 2024 32,466 769,474 (1%) 0% 1.1 35,713 Common Stock
Chin Lee Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.13 per share. 04 Dec 2024 10,634 275,046 (0%) 0% 1.1 12,016 Common Stock
Robert Alexander Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.58 per share. 11 Sep 2024 37,311 801,940 (1%) 0% 0.6 21,640 Common Stock
Chin Lee Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.65 per share. 09 Sep 2024 45,320 285,680 (0%) 0% 0.7 29,458 Common Stock
H. Baird Radford Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.65 per share. 06 Sep 2024 13,665 190,725 (0%) 0% 0.6 8,882 Common Stock
Adam Tomasi President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.65 per share. 06 Sep 2024 21,961 553,763 (1%) 0% 0.7 14,275 Common Stock
H. Baird Radford Chief Financial Officer Sale of securities on an exchange or to another person at price $ 1.01 per share. 28 Jun 2024 87,064 204,390 (0%) 0% 1.0 87,935 Common Stock
Adam Tomasi President Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.12 per share. 07 Jun 2024 24,749 572,724 (1%) 0% 1.1 27,719 Common Stock
Robert Alexander Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.14 per share. 06 Jun 2024 37,525 836,251 (1%) 0% 1.1 42,779 Common Stock
H. Baird Radford Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.19 per share. 04 Jun 2024 14,565 291,454 (0%) 0% 1.2 17,332 Common Stock
Robert E. Andreatta Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2024 41,000 41,000 - - Stock Option (Right to buy)
Steven P. James Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2024 41,000 41,000 - - Stock Option (Right to buy)
Dolca Thomas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2024 41,000 41,000 - - Stock Option (Right to buy)
Amy L. Ladd Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2024 41,000 41,000 - - Stock Option (Right to buy)
Neil Graham Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2024 41,000 41,000 - - Stock Option (Right to buy)
Paul Walker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2024 41,000 41,000 - - Stock Option (Right to buy)
H. Baird Radford Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.35 per share. 06 Mar 2024 32,142 306,019 (0%) 0% 1.4 43,392 Common Stock
Adam Tomasi President Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.44 per share. 05 Mar 2024 47,392 597,473 (1%) 0% 1.4 68,244 Common Stock
Robert Alexander Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.48 per share. 04 Mar 2024 70,910 873,776 (1%) 0% 1.5 104,947 Common Stock
Alexander Robert Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Feb 2024 2,000,000 2,000,000 - - Stock Option (Right to buy)
Tomasi Adam President Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Feb 2024 1,200,000 1,200,000 - - Stock Option (Right to buy)
Lee Chin Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Feb 2024 500,000 500,000 - - Stock Option (Right to buy)
H. Radford Baird Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Feb 2024 900,000 900,000 - - Stock Option (Right to buy)
Alexander Robert Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.50 per share. 04 Dec 2023 24,753 941,686 (1%) 0% 2.5 61,883 Common Stock
Adam Tomasi President Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.50 per share. 04 Dec 2023 16,054 641,865 (1%) 0% 2.5 40,135 Common Stock
Craig Paterson Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.50 per share. 04 Dec 2023 6,992 323,472 (0%) 0% 2.5 17,480 Common Stock
Baird H. Radford Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.50 per share. 04 Dec 2023 8,380 338,161 (0%) 0% 2.5 20,950 Common Stock
Neil Graham Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Aug 2023 154,786 154,786 - - Stock Option (Right to buy)
Dolca Thomas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2023 154,786 154,786 - - Stock Option (Right to buy)
Everett Rand Sutherland Director 01 Aug 2023 154,786 154,786 - - Stock Option (Right to buy)
H. Baird Radford Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.13 per share. 02 Jun 2023 8,942 356,052 (0%) 0% 5.1 45,872 Common Stock
Robert Alexander Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.13 per share. 02 Jun 2023 26,415 957,862 (1%) 0% 5.1 135,509 Common Stock
Adam Tomasi President Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.13 per share. 02 Jun 2023 17,129 673,138 (1%) 0% 5.1 87,872 Common Stock
Craig Paterson Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.13 per share. 02 Jun 2023 7,460 338,399 (0%) 0% 5.1 38,270 Common Stock
Daniel S. Janney Director 25 May 2023 86,762 86,762 - - Stock Option (Right to buy)
Robert E. Andreatta Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2023 86,762 86,762 - - Stock Option (Right to buy)
Steven P. James Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2023 86,762 86,762 - - Stock Option (Right to buy)
Paul Walker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2023 86,762 86,762 - - Stock Option (Right to buy)
Amy L. Ladd Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2023 86,762 86,762 - - Stock Option (Right to buy)
Robert Alexander Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.24 per share. 07 Mar 2023 66,274 984,277 (2%) 0% 6.2 413,550 Common Stock
Robert Alexander Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.40 per share. 07 Mar 2023 9,143 1,050,551 (2%) 0% 6.4 58,515 Common Stock
Adam Tomasi President Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.34 per share. 06 Mar 2023 57,467 690,267 (1%) 0% 5.3 306,874 Common Stock
H. Baird Radford Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.75 per share. 03 Mar 2023 33,907 364,994 (0%) 0% 5.7 194,965 Common Stock
Craig Paterson Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.83 per share. 02 Mar 2023 26,615 345,859 (0%) 0% 5.8 155,165 Common Stock
H. Baird Radford Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2023 126,640 398,901 (0%) 0% 0 Common Stock
H. Baird Radford Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2023 194,144 194,144 - - Stock Option (Right to buy)
Robert Alexander Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2023 462,325 462,325 - - Stock Option (Right to buy)
Robert Alexander Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2023 301,575 1,056,694 (2%) 0% 0 Common Stock
Adam Tomasi President Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2023 195,997 744,734 (1%) 0% 0 Common Stock
Adam Tomasi President Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2023 300,471 300,471 - - Stock Option (Right to buy)
Craig Paterson Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2023 157,428 157,428 - - Stock Option (Right to buy)
Craig Paterson Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2023 102,690 372,474 (0%) 0% 0 Common Stock
H. Baird Radford Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.11 per share. 02 Dec 2022 3,843 272,261 (0%) 0% 8.1 31,167 Common Stock
Robert Alexander Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.11 per share. 02 Dec 2022 15,152 755,119 (1%) 0% 8.1 122,883 Common Stock
Adam Tomasi President and COO Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.11 per share. 02 Dec 2022 9,783 548,737 (1%) 0% 8.1 79,340 Common Stock
Craig Paterson Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.11 per share. 02 Dec 2022 4,863 269,784 (0%) 0% 8.1 39,439 Common Stock
Daniel S. Janney Director, Ten Percent Owner 21 Sep 2022 475,000 2,546,147 (5%) 0% 5.0 2,384,500 Common Stock
Paul Walker Director Purchase of securities on an exchange or from another person at price $ 5.02 per share. 21 Sep 2022 3,386,400 3,386,400 (6%) 6% 5.0 16,999,728 Common Stock
Paul Walker Director Purchase of securities on an exchange or from another person at price $ 5.02 per share. 21 Sep 2022 597,600 2,760,860 (5%) 1% 5.0 2,999,952 Common Stock
H. Baird Radford Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.54 per share. 02 Sep 2022 585 276,104 (0%) 0% 4.5 2,656 Common Stock
Robert Alexander Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.54 per share. 02 Sep 2022 8,316 770,271 (1%) 0% 4.5 37,755 Common Stock
Adam Tomasi President and COO Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.54 per share. 02 Sep 2022 5,369 558,520 (1%) 0% 4.5 24,375 Common Stock
Craig Paterson Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.54 per share. 02 Sep 2022 1,129 274,647 (0%) 0% 4.5 5,126 Common Stock
Margaret Nell Fitzgerald General Counsel and Secretary Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.54 per share. 02 Sep 2022 335 153,128 (0%) 0% 4.5 1,521 Common Stock
Amy L. Ladd Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jul 2022 233,177 233,177 - - Stock Option (Right to buy)
H. Baird Radford Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.75 per share. 02 Jun 2022 2,274 276,689 (0%) 0% 2.8 6,254 Common Stock
Robert Alexander Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.75 per share. 02 Jun 2022 8,084 778,587 (1%) 0% 2.8 22,231 Common Stock
Adam Tomasi President and COO Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.75 per share. 02 Jun 2022 5,219 563,889 (1%) 0% 2.7 14,352 Common Stock
Craig Paterson Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.75 per share. 02 Jun 2022 226 275,776 (0%) 0% 2.8 622 Common Stock
Margaret Nell Fitzgerald General Counsel and Secretary Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.75 per share. 02 Jun 2022 318 150,463 (0%) 0% 2.8 875 Common Stock
Daniel S. Janney Director 25 May 2022 99,590 99,590 - - Stock Option (Right to buy)
John P. Mckearn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2022 99,590 99,590 - - Stock Option (Right to buy)
Robert E. Andreatta Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2022 99,590 99,590 - - Stock Option (Right to buy)
Steven P. James Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2022 99,590 99,590 - - Stock Option (Right to buy)
Paul Walker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2022 99,590 99,590 - - Stock Option (Right to Buy)
Margaret Nell Fitzgerald General Counsel and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Apr 2022 57,637 150,781 (0%) 0% 0 Common Stock
Mark Asbury CLO, GC and Secretary Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.38 per share. 02 Mar 2022 1,680 226,935 (0%) 0% 5.4 9,038 Common Stock
Robert Alexander Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.38 per share. 02 Mar 2022 8,215 786,671 (1%) 0% 5.4 44,197 Common Stock
Adam Tomasi President and COO Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.38 per share. 02 Mar 2022 5,582 569,108 (1%) 0% 5.4 30,031 Common Stock
H. Baird Radford Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2022 237,608 278,963 (0%) 0% 0 Common Stock
Mark Asbury CLO, GC and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2022 140,490 228,615 (0%) 0% 0 Common Stock
Robert Alexander Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2022 529,323 794,886 (1%) 1% 0 Common Stock
Adam Tomasi President and COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2022 344,060 574,690 (1%) 0% 0 Common Stock
Steven P. James Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.52 per share. 28 Sep 2021 4,000 4,000 (0%) 0% 0.5 2,100 Common Stock
Steven P. James Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Sep 2021 4,000 55,380 - - Stock Option (Right to buy)
Steven P. James Director Sale of securities on an exchange or to another person at price $ 108.12 per share. 28 Sep 2021 4,000 0 (0%) 0% 108.1 432,480 Common Stock
Mark Asbury CLO, GC and Secretary Payment of exercise price or tax liability using portion of securities received from the company at price $ 91.66 per share. 02 Sep 2021 698 61,810 (0%) 0% 91.7 63,979 Common Stock
Robert Alexander Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 91.66 per share. 02 Sep 2021 3,985 233,810 (0%) 0% 91.7 365,265 Common Stock
Adam Tomasi President and COO Payment of exercise price or tax liability using portion of securities received from the company at price $ 91.66 per share. 02 Sep 2021 2,346 210,022 (0%) 0% 91.7 215,034 Common Stock
Adam Tomasi President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.31 per share. 31 Aug 2021 64,148 212,368 (0%) 0% 4.3 276,638 Common Stock
Adam Tomasi President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Aug 2021 64,148 88,036 - - Stock Option (Right to buy)
Adam Tomasi President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.69 per share. 14 Jun 2021 20,000 168,220 (0%) 0% 0.7 13,750 Common Stock
Adam Tomasi President and COO Sale of securities on an exchange or to another person at price $ 91.62 per share. 14 Jun 2021 20,000 148,220 (0%) 0% 91.6 1,832,362 Common Stock
Adam Tomasi President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.69 per share. 14 Jun 2021 20,000 168,220 (0%) 0% 0.7 13,750 Common Stock
Adam Tomasi President and COO Sale of securities on an exchange or to another person at price $ 91.03 per share. 14 Jun 2021 20,000 148,220 (0%) 0% 91.0 1,820,502 Common Stock
Adam Tomasi President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Jun 2021 20,000 506,400 - - Stock Option (Right to buy)
Adam Tomasi President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Jun 2021 20,000 486,400 - - Stock Option (Right to buy)
Adam Tomasi President and COO Sale of securities on an exchange or to another person at price $ 90.26 per share. 03 Jun 2021 642 150,707 (0%) 0% 90.3 57,947 Common Stock
Adam Tomasi President and COO Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.20 per share. 03 Jun 2021 1,777 151,349 (0%) 0% 92.2 163,839 Common Stock
Adam Tomasi President and COO Sale of securities on an exchange or to another person at price $ 92.03 per share. 03 Jun 2021 2,487 148,220 (0%) 0% 92.0 228,879 Common Stock
Daniel S. Janney Director 25 May 2021 7,700 7,700 - - Stock Option (Right to buy)
John P. Mckearn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2021 7,700 7,700 - - Stock Option (Right to buy)
Robert E. Andreatta Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2021 7,700 7,700 - - Stock Option (Right to buy)
Steven P. James Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2021 7,700 7,700 - - Stock Option (Right to buy)
Paul Walker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2021 7,700 7,700 - - Stock Option (Right to buy)
Natalie C. Holles Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2021 7,700 7,700 - - Stock Option (Right to buy)
Robert Alexander Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 102.32 per share. 17 May 2021 14,517 245,395 (0%) 0% 102.3 1,485,379 Common Stock
Robert Alexander Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 May 2021 14,517 985,083 - - Stock Option (Right to buy)
Robert Alexander Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 May 2021 14,517 970,566 - - Stock Option (Right to buy)
Robert Alexander Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 May 2021 14,516 956,050 - - Stock Option (Right to buy)
Robert Alexander Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 99.69 per share. 17 May 2021 5,484 347,716 (0%) 0% 99.7 546,700 Common Stock
Robert Alexander Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 102.29 per share. 17 May 2021 5,484 342,232 (0%) 0% 102.3 560,958 Common Stock
Robert Alexander Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 98.89 per share. 17 May 2021 5,482 336,750 (0%) 0% 98.9 542,115 Common Stock
Robert Alexander Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.69 per share. 17 May 2021 14,517 259,912 (0%) 0% 0.7 9,980 Common Stock
Robert Alexander Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 99.68 per share. 17 May 2021 14,517 245,395 (0%) 0% 99.7 1,447,055 Common Stock
Robert Alexander Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.69 per share. 17 May 2021 14,517 259,912 (0%) 0% 0.7 9,980 Common Stock
Robert Alexander Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.69 per share. 17 May 2021 14,516 259,911 (0%) 0% 0.7 9,980 Common Stock
Robert Alexander Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 98.94 per share. 17 May 2021 14,516 245,395 (0%) 0% 98.9 1,436,213 Common Stock
Adam Tomasi President and COO Sale of securities on an exchange or to another person at price $ 99.23 per share. 10 May 2021 20,000 153,126 (0%) 0% 99.2 1,984,600 Common Stock
Adam Tomasi President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 May 2021 20,000 566,400 - - Stock Option (Right to buy)
Adam Tomasi President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 May 2021 20,000 546,400 - - Stock Option (Right to buy)
Adam Tomasi President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 May 2021 20,000 526,400 - - Stock Option (Right to buy)
Adam Tomasi President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.69 per share. 10 May 2021 20,000 173,126 (0%) 0% 0.7 13,750 Common Stock
Adam Tomasi President and COO Sale of securities on an exchange or to another person at price $ 96.02 per share. 10 May 2021 20,000 153,126 (0%) 0% 96.0 1,920,400 Common Stock
Adam Tomasi President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.69 per share. 10 May 2021 20,000 173,126 (0%) 0% 0.7 13,750 Common Stock
Adam Tomasi President and COO Sale of securities on an exchange or to another person at price $ 97.79 per share. 10 May 2021 20,000 153,126 (0%) 0% 97.8 1,955,800 Common Stock
Adam Tomasi President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.69 per share. 10 May 2021 20,000 173,126 (0%) 0% 0.7 13,750 Common Stock
H. Baird Radford Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Apr 2021 27,600 27,600 - - Stock Option (Right to buy)
H. Baird Radford Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Apr 2021 17,100 17,100 (0%) 0% 0 Common Stock
Adam Tomasi President, COO and CFO Sale of securities on an exchange or to another person at price $ 107.77 per share. 12 Apr 2021 20,000 153,126 (0%) 0% 107.8 2,155,400 Common Stock
Adam Tomasi President, COO and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Apr 2021 20,000 626,400 - - Stock Option (Right to buy)
Adam Tomasi President, COO and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Apr 2021 20,000 606,400 - - Stock Option (Right to buy)
Adam Tomasi President, COO and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Apr 2021 20,000 586,400 - - Stock Option (Right to buy)
Adam Tomasi President, COO and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.69 per share. 12 Apr 2021 20,000 173,126 (0%) 0% 0.7 13,750 Common Stock
Adam Tomasi President, COO and CFO Sale of securities on an exchange or to another person at price $ 104.40 per share. 12 Apr 2021 20,000 153,126 (0%) 0% 104.4 2,088,000 Common Stock
Adam Tomasi President, COO and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.69 per share. 12 Apr 2021 20,000 173,126 (0%) 0% 0.7 13,750 Common Stock
Adam Tomasi President, COO and CFO Sale of securities on an exchange or to another person at price $ 103.08 per share. 12 Apr 2021 20,000 153,126 (0%) 0% 103.1 2,061,600 Common Stock
Adam Tomasi President, COO and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.69 per share. 12 Apr 2021 20,000 173,126 (0%) 0% 0.7 13,750 Common Stock
Henrik S. Rasmussen Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Apr 2021 10,000 282,000 - - Stock Option (Right to buy)
Henrik S. Rasmussen Chief Medical Officer Sale of securities on an exchange or to another person at price $ 111.68 per share. 01 Apr 2021 10,000 101,819 (0%) 0% 111.7 1,116,800 Common Stock
Henrik S. Rasmussen Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.16 per share. 01 Apr 2021 10,000 111,819 (0%) 0% 1.2 11,625 Common Stock
Henrik S. Rasmussen Chief Medical Officer Sale of securities on an exchange or to another person at price $ 113.06 per share. 01 Apr 2021 20,000 101,819 (0%) 0% 113.1 2,261,200 Common Stock
Henrik S. Rasmussen Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.16 per share. 01 Apr 2021 20,000 121,819 (0%) 0% 1.2 23,250 Common Stock
Henrik S. Rasmussen Chief Medical Officer Sale of securities on an exchange or to another person at price $ 114.40 per share. 01 Apr 2021 20,000 101,819 (0%) 0% 114.4 2,288,000 Common Stock
Henrik S. Rasmussen Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.16 per share. 01 Apr 2021 20,000 121,819 (0%) 0% 1.2 23,250 Common Stock
Henrik S. Rasmussen Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Apr 2021 20,000 292,000 - - Stock Option (Right to buy)
Henrik S. Rasmussen Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Apr 2021 20,000 312,000 - - Stock Option (Right to buy)
Daniel S. Janney Director, Ten Percent Owner 26 Mar 2021 2,500 56,293 (0%) 0% 116.1 290,225 Common Stock
Daniel S. Janney Director, Ten Percent Owner 26 Mar 2021 14,808 58,793 (0%) 0% 115.0 1,703,068 Common Stock
John P. Mckearn Director Gift of securities by or to the insider at price $ 0.00 per share. 26 Mar 2021 1,200 0 (0%) 0% 0 Common Stock
John P. Mckearn Director Sale of securities on an exchange or to another person at price $ 115.00 per share. 26 Mar 2021 7,439 1,200 (0%) 0% 115 855,485 Common Stock
Daniel S. Janney Director, Ten Percent Owner 22 Mar 2021 9,030 77,719 (0%) 0% 119.5 1,078,724 Common Stock
Daniel S. Janney Director, Ten Percent Owner 22 Mar 2021 4,118 73,601 (0%) 0% 120.2 495,066 Common Stock
Steven P. James Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.53 per share. 16 Mar 2021 3,500 3,500 (0%) 0% 0.5 1,838 Common Stock
Steven P. James Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Mar 2021 3,500 59,380 - - Stock Option (Right to buy)
Steven P. James Director Sale of securities on an exchange or to another person at price $ 121.65 per share. 16 Mar 2021 3,500 0 (0%) 0% 121.7 425,775 Common Stock
Robert Alexander Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.69 per share. 15 Mar 2021 20,000 265,395 (0%) 0% 0.7 13,750 Common Stock
Robert Alexander Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Mar 2021 20,000 1,039,600 - - Stock Option (Right to buy)
Robert Alexander Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Mar 2021 20,000 1,019,600 - - Stock Option (Right to buy)
Robert Alexander Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Mar 2021 20,000 999,600 - - Stock Option (Right to buy)
Robert Alexander Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.69 per share. 15 Mar 2021 20,000 265,395 (0%) 0% 0.7 13,750 Common Stock
Robert Alexander Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 122.78 per share. 15 Mar 2021 20,000 245,395 (0%) 0% 122.8 2,455,600 Common Stock
Robert Alexander Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.69 per share. 15 Mar 2021 20,000 265,395 (0%) 0% 0.7 13,750 Common Stock
Robert Alexander Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 121.76 per share. 15 Mar 2021 20,000 245,395 (0%) 0% 121.8 2,435,200 Common Stock
Robert Alexander Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 121.14 per share. 15 Mar 2021 20,000 245,395 (0%) 0% 121.1 2,422,800 Common Stock
Daniel S. Janney Director, Ten Percent Owner 12 Mar 2021 4,071 93,457 (0%) 0% 124.2 505,537 Common Stock
Daniel S. Janney Director, Ten Percent Owner 12 Mar 2021 6,708 86,749 (0%) 0% 124.6 835,548 Common Stock
Daniel S. Janney Director, Ten Percent Owner 09 Mar 2021 100 103,534 (0%) 0% 125 12,500 Common Stock
Daniel S. Janney Director, Ten Percent Owner 09 Mar 2021 6,006 97,528 (0%) 0% 124.6 748,468 Common Stock
Adam Tomasi President, COO and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.69 per share. 08 Mar 2021 20,000 173,126 (0%) 0% 0.7 13,750 Common Stock
Adam Tomasi President, COO and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Mar 2021 20,000 686,400 - - Stock Option (Right to buy)
Adam Tomasi President, COO and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Mar 2021 20,000 666,400 - - Stock Option (Right to buy)
Adam Tomasi President, COO and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Mar 2021 20,000 646,400 - - Stock Option (Right to buy)
Adam Tomasi President, COO and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.69 per share. 08 Mar 2021 20,000 173,126 (0%) 0% 0.7 13,750 Common Stock
Adam Tomasi President, COO and CFO Sale of securities on an exchange or to another person at price $ 122.78 per share. 08 Mar 2021 20,000 153,126 (0%) 0% 122.8 2,455,600 Common Stock
Adam Tomasi President, COO and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.69 per share. 08 Mar 2021 20,000 173,126 (0%) 0% 0.7 13,750 Common Stock
Adam Tomasi President, COO and CFO Sale of securities on an exchange or to another person at price $ 121.78 per share. 08 Mar 2021 20,000 153,126 (0%) 0% 121.8 2,435,600 Common Stock
Adam Tomasi President, COO and CFO Sale of securities on an exchange or to another person at price $ 121.78 per share. 08 Mar 2021 20,000 153,126 (0%) 0% 121.8 2,435,600 Common Stock
Mark Asbury CLO, GC and Secretary Payment of exercise price or tax liability using portion of securities received from the company at price $ 117.82 per share. 02 Mar 2021 733 63,242 (0%) 0% 117.8 86,362 Common Stock
Robert Alexander Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 117.82 per share. 02 Mar 2021 3,890 245,395 (0%) 0% 117.8 458,320 Common Stock
Adam Tomasi President, COO and CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 117.82 per share. 02 Mar 2021 1,717 156,315 (0%) 0% 117.8 202,297 Common Stock
Adam Tomasi President, COO and CFO Sale of securities on an exchange or to another person at price $ 113.56 per share. 02 Mar 2021 3,189 153,126 (0%) 0% 113.6 362,143 Common Stock
Henrik S. Rasmussen Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.16 per share. 01 Mar 2021 20,000 125,087 (0%) 0% 1.2 23,250 Common Stock
Henrik S. Rasmussen Chief Medical Officer Sale of securities on an exchange or to another person at price $ 117.32 per share. 01 Mar 2021 20,000 105,087 (0%) 0% 117.3 2,346,400 Common Stock
Henrik S. Rasmussen Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 117.82 per share. 01 Mar 2021 1,316 103,771 (0%) 0% 117.8 155,051 Common Stock
Henrik S. Rasmussen Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.16 per share. 01 Mar 2021 20,000 123,771 (0%) 0% 1.2 23,250 Common Stock
Henrik S. Rasmussen Chief Medical Officer Sale of securities on an exchange or to another person at price $ 113.00 per share. 01 Mar 2021 20,000 103,771 (0%) 0% 113 2,260,000 Common Stock
Henrik S. Rasmussen Chief Medical Officer Sale of securities on an exchange or to another person at price $ 112.83 per share. 01 Mar 2021 1,952 101,819 (0%) 0% 112.8 220,244 Common Stock
Henrik S. Rasmussen Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Mar 2021 20,000 372,000 - - Stock Option (Right to buy)
Henrik S. Rasmussen Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Mar 2021 20,000 352,000 - - Stock Option (Right to buy)
Henrik S. Rasmussen Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Mar 2021 20,000 332,000 - - Stock Option (Right to buy)
Henrik S. Rasmussen Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.16 per share. 01 Mar 2021 20,000 125,087 (0%) 0% 1.2 23,250 Common Stock
Henrik S. Rasmussen Chief Medical Officer Sale of securities on an exchange or to another person at price $ 120.66 per share. 01 Mar 2021 20,000 105,087 (0%) 0% 120.7 2,413,200 Common Stock
John P. Mckearn Director Other type of transaction at price $ 0.00 per share. 18 Feb 2021 8,016 8,639 (0%) 0% 0 Common Stock
John P. Mckearn Director Other type of transaction at price $ 0.00 per share. 18 Feb 2021 47,494 4,887,932 (10%) 0% 0 Common Stock
John P. Mckearn Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 04 Jan 2021 862,574 4,935,426 (10%) 1% 0 Common Stock
John P. Mckearn Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 04 Jan 2021 623 623 (0%) 0% 0 Common Stock
Natalie C. Holles Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2021 4,000 4,000 - - Stock Option (Right to buy)
Robert Alexander Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Dec 2020 8,240 306,960 - - Stock Option (Right to buy)
Robert Alexander Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.31 per share. 29 Dec 2020 8,240 241,105 (0%) 0% 4.3 35,535 Common Stock
Adam Tomasi President, COO and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Dec 2020 5,416 152,184 - - Stock Option (Right to buy)
Adam Tomasi President, COO and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.31 per share. 29 Dec 2020 5,416 157,757 (0%) 0% 4.3 23,357 Common Stock
Henrik S. Rasmussen Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 99.04 per share. 01 Dec 2020 3,954 104,812 (0%) 0% 99.0 391,604 Common Stock
Henrik S. Rasmussen Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2020 52,300 108,766 (0%) 0% 0 Common Stock
Mark Asbury CLO, GC and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2020 32,400 66,234 (0%) 0% 0 Common Stock
Mark Asbury CLO, GC and Secretary Payment of exercise price or tax liability using portion of securities received from the company at price $ 99.04 per share. 01 Dec 2020 2,977 63,257 (0%) 0% 99.0 294,842 Common Stock
Robert Alexander Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 99.04 per share. 01 Dec 2020 14,501 232,865 (0%) 0% 99.0 1,436,179 Common Stock
Robert Alexander Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2020 121,600 247,366 (0%) 0% 0 Common Stock
Adam Tomasi President and COO Payment of exercise price or tax liability using portion of securities received from the company at price $ 99.04 per share. 01 Dec 2020 8,825 152,341 (0%) 0% 99.0 874,028 Common Stock
Adam Tomasi President and COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2020 78,500 161,166 (0%) 0% 0 Common Stock
Leo Redmond Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 99.04 per share. 01 Dec 2020 2,472 51,958 (0%) 0% 99.0 244,827 Common Stock
Leo Redmond Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2020 26,900 54,430 (0%) 0% 0 Common Stock
Daniel S. Janney Director 26 May 2020 7,700 7,700 - - Stock Option (Right to Buy)
John P. Mckearn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 May 2020 7,700 7,700 - - Stock Option (Right to Buy)
Robert E. Andreatta Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 May 2020 7,700 7,700 - - Stock Option (Right to Buy)
Steven P. James Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 May 2020 7,700 7,700 - - Stock Option (Right to Buy)
Paul Walker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 May 2020 7,700 7,700 - - Stock Option (Right to Buy)
John P. Mckearn Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 71.04 per share. 12 May 2020 1,150,000 5,750,506 (11%) 2% 71.0 81,696,000 Common Stock
Henrik S. Rasmussen Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Nov 2019 52,300 55,077 (0%) 0% 0 Common Stock
Mark Asbury Other Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Nov 2019 32,400 33,117 (0%) 0% 0 Common Stock
Robert Alexander Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Nov 2019 121,600 124,377 (0%) 0% 0 Common Stock
Adam Tomasi President and COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Nov 2019 78,500 81,277 (0%) 0% 0 Common Stock
Leo Redmond Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Nov 2019 26,900 26,900 (0%) 0% 0 Common Stock
Leo Redmond Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2019 120,000 120,000 - - Stock Option (Right to Buy)
John P. Mckearn Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 40.58 per share. 07 Jun 2019 7,100 6,900,738 (14%) 0% 40.6 288,118 Common Stock
John P. Mckearn Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 41.05 per share. 07 Jun 2019 232 6,900,506 (14%) 0% 41.1 9,524 Common Stock
John P. Mckearn Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 39.62 per share. 07 Jun 2019 31,400 6,907,838 (14%) 0% 39.6 1,244,068 Common Stock
Daniel S. Janney None 06 Jun 2019 16,000 16,000 - - Stock Option (Right to Buy)
John P. Mckearn None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2019 16,000 16,000 - - Stock Option (Right to Buy)
Robert E. Andreatta None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2019 16,000 16,000 - - Stock Option (Right to Buy)
Steven P. James None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2019 16,000 16,000 - - Stock Option (Right to Buy)
Paul Walker None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2019 16,000 16,000 - - Stock Option (Right to Buy)
John P. Mckearn Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 39.49 per share. 04 Jun 2019 6,248 7,004,631 (14%) 0% 39.5 246,734 Common Stock
John P. Mckearn Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 40.40 per share. 04 Jun 2019 900 7,032,073 (14%) 0% 40.4 36,360 Common Stock
John P. Mckearn Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 39.50 per share. 04 Jun 2019 21,194 7,010,879 (14%) 0% 39.5 837,163 Common Stock
John P. Mckearn Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 39.81 per share. 04 Jun 2019 17,500 6,987,131 (14%) 0% 39.8 696,675 Common Stock
John P. Mckearn Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 40.01 per share. 04 Jun 2019 47,893 6,939,238 (14%) 0% 40.0 1,916,199 Common Stock
John P. Mckearn Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 43.27 per share. 30 May 2019 600 7,086,279 (14%) 0% 43.3 25,962 Common Stock
John P. Mckearn Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 39.63 per share. 30 May 2019 22,049 7,035,573 (14%) 0% 39.6 873,802 Common Stock
John P. Mckearn Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 40.16 per share. 30 May 2019 4,257 7,057,622 (14%) 0% 40.2 170,961 Common Stock
John P. Mckearn Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 38.97 per share. 30 May 2019 2,600 7,032,973 (14%) 0% 39.0 101,322 Common Stock
John P. Mckearn Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 39.12 per share. 30 May 2019 17,321 7,061,879 (14%) 0% 39.1 677,598 Common Stock
John P. Mckearn Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 40.06 per share. 30 May 2019 7,079 7,079,200 (14%) 0% 40.1 283,585 Common Stock
Mark Asbury Other Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Apr 2019 39,910 39,910 - - Stock Option (Right to Buy)
John P. Mckearn Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 36.33 per share. 16 Apr 2019 35,889 7,110,307 (14%) 0% 36.3 1,303,847 Common Stock
John P. Mckearn Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 34.82 per share. 16 Apr 2019 1,028 7,086,879 (14%) 0% 34.8 35,795 Common Stock
John P. Mckearn Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 36.07 per share. 16 Apr 2019 2,400 7,087,907 (14%) 0% 36.1 86,568 Common Stock
John P. Mckearn Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 36.33 per share. 16 Apr 2019 20,000 7,090,307 (14%) 0% 36.3 726,600 Common Stock
John P. Mckearn Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 37.23 per share. 16 Apr 2019 22,679 7,153,517 (14%) 0% 37.2 844,339 Common Stock
John P. Mckearn Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 36.80 per share. 16 Apr 2019 7,321 7,146,196 (14%) 0% 36.8 269,413 Common Stock
John P. Mckearn Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 35.03 per share. 15 Feb 2019 9,228 7,309,187 (15%) 0% 35.0 323,257 Common Stock
John P. Mckearn Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 34.34 per share. 15 Feb 2019 92,219 7,176,196 (14%) 0% 34.3 3,166,800 Common Stock
John P. Mckearn Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 34.72 per share. 15 Feb 2019 40,772 7,268,415 (14%) 0% 34.7 1,415,604 Common Stock
John P. Mckearn Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 43.26 per share. 24 Jan 2019 12,955 7,278,533 (14%) 0% 43.3 560,433 Common Stock
John P. Mckearn Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 42.42 per share. 24 Jan 2019 39,882 7,318,415 (15%) 0% 42.4 1,691,794 Common Stock
Henrik S. Rasmussen Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Oct 2018 80,000 80,000 - - Stock Option (Right to buy)
Robert Alexander Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Oct 2018 250,000 250,000 - - Stock Option (Right to buy)
Adam Tomasi COO, CFO and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Oct 2018 125,000 125,000 - - Stock Option (Right to buy)
Daniel S. Janney Director, Ten Percent Owner 23 Jul 2018 11,269,200 11,269,200 (27%) 27% 0 Common Stock
Daniel S. Janney Director, Ten Percent Owner 23 Jul 2018 250,000 11,519,200 (28%) 0% 18 4,500,000 Common Stock
Daniel S. Janney Director, Ten Percent Owner 23 Jul 2018 1,239,007 0 - - Series B Preferred Stock
Daniel S. Janney Director, Ten Percent Owner 23 Jul 2018 10,030,193 0 - - Series A Preferred Stock
John P. Mckearn Director, Ten Percent Owner 23 Jul 2018 777,417 0 - - Series B Preferred Stock
John P. Mckearn Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 18.00 per share. 23 Jul 2018 111,111 7,371,252 (18%) 0% 18 1,999,998 Common Stock
John P. Mckearn Director, Ten Percent Owner 23 Jul 2018 7,260,141 7,260,141 (17%) 17% 0 Common Stock
John P. Mckearn Director, Ten Percent Owner 23 Jul 2018 6,482,724 0 - - Series A Preferred Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters